అకౌంట్స్ గమనికలుClinitech Laboratory Ltd.

Mar 31, 2025

Rights, preferences and restrictions attached to shares

The Company has issued only one class of equity shares having a par value of Rs. 10 per share. Each equity shareholder is entitled to one vote per share. In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining assets of the Company, after distribution of all preferential amounts, in proportion to their shareholding. Any dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting, except in case of interim dividend.

Details regarding number and class of shares for the period of five years immediately preceding March 31, 2025

a) The company has not allotted any shares as fully paid-up without payment being received in cash.

b) The company has not alloted any shares as fully paid up bonus shares.

c) The company has not bought back any of its shares.

Other Details regarding issue of shares

There are no shares reserved for issue under options and contracts / commitments for the sale of shares.

There are no securities convertible into equity or preference shares.

There are no calls unpaid on any shares.

There are no forfeited shares.

Outstanding is drawn based on the invoice date. The above amounts excludes retention amounts

Dues to Micro and Small Enterprises as aforesaid have been determined to the extent such parties have been identified on the basis of information collected by the Management. Provision for interest is not required in the opinion of management as there has been no delay and the payments are as per regular business agreements of the entity.

The estimates of future salary increases, considered in actuarial valuation, taken account of inflation, seniority, promotion and other Amounts Recognised as Expense:

i) Defined Contribution Plan

a) Employer''s Contribution to Provident Fund has been included in Note No 21 under Employee Benefit Expenses

b) Employer''s Contribution to ESIC has been included in Note No. 21 under Employee Benefit Expenses

ii) Defined Benefit Plan

Gratuity Provision has been included in Note No 21 under Employee Benefit Expenses

Earning available for debt service = Profit for the year (before taxes) Finance costs Depreciation and Amortisation Expense Total debt service = Finance costs Principal Repayments

Capital employed = Shareholders'' funds Long Term Borrowings Short Term Borrowings Deferred Tax Liabilities (Net) -Intangible assets - Intangible Assets under development 31 Other Disclosures

Disclosure requirements as notified by MCA pursuant to amended Schedule III:

- The Company has not traded or invested in Crypto currency or Virtual Currency during the financial year.

- The Company does not have any Benami Property under Prohibition of Benami Property Transactions Act, 1988.

- The Company has not been declared a wilful defaulter by any lender who has powers to declare a company as a wilful defaulter.

- The Company has no Scheme of Arrangement approved by the competent authority specified under Section 230 to 237 of the

Companies Act, 2013.

The accompanyi ng note s are tin integral part o f the Financial Statements